Nutreco
- Consolidated income statement
- Consolidated statement of comprehensive income
- Consolidated balance sheet
- Statement of changes in equity
- Consolidated cash flow statement
- Notes to the consolidated financial statements
- (1) Accounting policies used for the consolidated financial statements of Nutreco Holding N.V.
- (2) Reconciliation consolidated income statement
- (3) Operating segments
- (4) Discontinued operations and divestments
- (5) Assets and liabilities held for sale
- (6) Acquisitions
- (7) Other operating income
- (8) Personnel costs
- (9) Other operating expenses
- (10) Net financing costs
- (11) Income tax expense
- (12) Earnings per share
- (13) Property, plant and equipment
- (14) Intangible assets
- (15) Investments in associates
- (16) Other investments
- (17) Deferred tax assets and liabilities
- (18) Inventories
- (19) Biological assets
- (20) Trade and other receivables
- (21) Cash and cash equivalents
- (22) Equity attributable to the equity holders of the parent
- (23) Interest-bearing borrowings
- (24) Employee benefits
- (25) Provisions
- (26) Trade and other payables
- (27) Financial instruments and risk management
- (28) Contingent assets and liabilities
- (29) Related party transactions
- (30) Subsequent events
- (31) Accounting estimates and judgements
- (32) Notes to the consolidated cash flow statement
Consolidated cash flow statement
|
(EUR x million) |
Note |
2009 |
2008 |
|
Total result for the period |
93.0 |
116.9 |
|
|
Net financing costs – continuing operations |
31.6 |
31.2 |
|
|
Share in results of associates |
-1.4 |
-2.1 |
|
|
Income tax expense – continuing operations |
34.7 |
37.2 |
|
|
Income tax expense – discontinued operations |
- |
-0.2 |
|
|
Impairment losses on long-lived assets |
8.8 |
0.1 |
|
|
Impairment losses other investments |
1.0 |
2.2 |
|
|
Impairment losses intangible assets continuing operations |
0.3 |
- |
|
|
Depreciation continuing operations |
52.7 |
50.6 |
|
|
Amortisation continuing operations |
12.1 |
10.8 |
|
|
Negative goodwill |
-11.2 |
-10.2 |
|
|
Equity settled share-based payment expense |
3.0 |
3.1 |
|
|
Changes in fair value of other investments |
- |
0.3 |
|
|
Changes in fair value of biological assets |
-2.2 |
0.5 |
|
|
Changes in fair value foreign exchange contracts |
-6.1 |
-1.8 |
|
|
Changes in fair value of commodity contracts |
- |
-1.9 |
|
|
Loss on sale of property, plant and equipment |
0.1 |
0.9 |
|
|
Gain on sale of intangible assets |
-4.4 |
- |
|
|
Cash flows from operating activities before changes in working capital and provisions |
212.0 |
237.6 |
|
|
Decrease/increase in working capital |
98.4 |
-51.7 |
|
|
Increase in employee benefits |
9.6 |
4.1 |
|
|
Increase/decrease in provisions |
6.1 |
-22.7 |
|
|
Cash generated from operations |
326.1 |
167.3 |
|
|
Interest received |
5.8 |
6.5 |
|
|
Interest paid |
-37.3 |
-39.3 |
|
|
Income taxes paid |
-28.1 |
-38.0 |
|
|
Dividends received |
0.5 |
1.5 |
|
|
Net cash from operating activities |
267.0 |
98.0 |
|
|
Acquisition of property, plant and equipment |
-50.1 |
-86.2 |
|
|
Acquisition of intangible assets |
-4.0 |
-4.0 |
|
|
Acquisition of group companies net of cash acquired |
-30.9 |
-66.0 |
|
|
Acquisition of associates |
-2.8 |
-0.1 |
|
|
Acquisition of other investments |
-11.6 |
-0.4 |
|
|
Proceeds from the sale of property, plant and equipment |
4.9 |
3.8 |
|
|
Proceeds from the sale of intangible assets |
5.9 |
- |
|
|
Disposal of subsidiaries net of cash disposed of |
1.5 |
- |
|
|
Proceeds from the sale of share in associates |
- |
2.0 |
|
|
Repayments on other investments |
5.0 |
3.6 |
|
|
Payments of transaction costs |
-4.3 |
-0.9 |
|
|
Net cash used in investing activities |
-86.4 |
-148.2 |
|
|
Usage of treasury shares |
1.3 |
1.4 |
|
|
Repurchase shares |
- |
-33.1 |
|
|
Dividends paid to equity holders of Nutreco |
-28.6 |
-32.0 |
|
|
Dividends paid to minority shareholders |
-1.2 |
-0.5 |
|
|
Repayment of borrowings |
-279.2 |
-158.9 |
|
|
Proceeds from borrowings |
173.8 |
291.6 |
|
|
Net cash used in/from financing activities |
-133.9 |
68.5 |
|
|
Increase in cash and cash equivalents |
46.7 |
18.3 |
|
|
Cash and cash equivalents at 1 January |
151.8 |
135.4 |
|
|
Effect of exchange rate fluctuations on cash held |
2.5 |
-1.9 |
|
|
Cash and cash equivalents at 31 December |
201.0 |
151.8 |
|
|
Cash and cash equivalents at 31 December |
232.6 |
228.3 |
|
|
Bank overdrafts at 31 December |
-31.6 |
-76.5 |
|
|
Cash and cash equivalents for the cash flow statement at 31 December |
201.0 |
151.8 |